Correlation Between NeuPath Health and CITIGROUP CDR

Can any of the company-specific risk be diversified away by investing in both NeuPath Health and CITIGROUP CDR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuPath Health and CITIGROUP CDR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuPath Health and CITIGROUP CDR, you can compare the effects of market volatilities on NeuPath Health and CITIGROUP CDR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuPath Health with a short position of CITIGROUP CDR. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuPath Health and CITIGROUP CDR.

Diversification Opportunities for NeuPath Health and CITIGROUP CDR

0.07

Correlation Coefficient

NeuPath Health  CITIGROUP CDR

Significant diversification

The 3 months correlation between NeuPath and CITIGROUP is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding NeuPath Health and CITIGROUP CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CITIGROUP CDR and NeuPath Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuPath Health are associated (or correlated) with CITIGROUP CDR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CITIGROUP CDR has no effect on the direction of NeuPath Health i.e., NeuPath Health and CITIGROUP CDR go up and down completely randomly.

Pair Corralation between NeuPath Health and CITIGROUP CDR

Assuming the 90 days trading horizon NeuPath Health is expected to generate 1.49 times less return on investment than CITIGROUP CDR. In addition to that, NeuPath Health is 2.04 times more volatile than CITIGROUP CDR. It trades about 0.08 of its total potential returns per unit of risk. CITIGROUP CDR is currently generating about 0.23 per unit of volatility. If you would invest  3,174  in CITIGROUP CDR on May 18, 2025 and sell it today you would earn a total of  746.00  from holding CITIGROUP CDR or generate 23.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

NeuPath Health  vs.  CITIGROUP CDR

NeuPath Health

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in NeuPath Health are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, NeuPath Health showed solid returns over the last few months and may actually be approaching a breakup point.

CITIGROUP CDR

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in CITIGROUP CDR are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, CITIGROUP CDR exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeuPath Health and CITIGROUP CDR

The main advantage of trading using opposite NeuPath Health and CITIGROUP CDR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuPath Health position performs unexpectedly, CITIGROUP CDR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CITIGROUP CDR will offset losses from the drop in CITIGROUP CDR's long position.

The idea behind NeuPath Health and CITIGROUP CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.